Clinical Research Directory

Inclusion Criteria: * Diagnosed with liver cirrhosis * Diagnosis of portal vein thrombosis through computed tomographic venography with a thrombus diameter exceeding 30% of the vessel diameter. * Consent to participate in the clinical trial and the signing of an informed consent form. Exclusion Criteria: * Presence of acute symptoms such as fever, abdominal pain or bleeding, or of cavernous transformation * Patients with Child-Pugh C. * Pregnant or lactating women. * With a history of liver cancer or other malignancy. * Severe heart, lung diseases, or significant renal dysfunction. * Allergies to anticoagulant medications, uncontrolled hypertension, history of cerebral hemorrhage, discovery of gastrointestinal ulcers, ulcerative colitis, subacute bacterial endocarditis, or other contraindications to anticoagulant drugs. * On concomitant therapy of immunosuppressive drugs. * With coagulation disorders other than liver disease. * With active variceal bleeding.